KIR2DL3 and COVID-19: The frequency of HLA-C1C1, the homozygous receptor for KIR2DL2 and KIR2DL3, was also higher in COVID-19 patients than in healthy controls (47.08% vs 22.45%, respectively; OR=3.074, P <0.001).